Epidermolytic hyperkeratosis a histological hallmark in the diagnosis of bullous ichthyosiform erythroderma
DOI:
https://doi.org/10.66344/jpad.19.3.2009.535Keywords:
Bullous ichthyosiform erythroderma, epidermolytic hyperkeratosisAbstract
Bullous ichthyosiform erythroderma is an uncommon form childhood keratinizing disorder. Early in life it is associated with generalized blistering and erythroderma. Later on it produces rippled type of hyperkeratosis. The diagnosis is confirmed by a very characteristic histopathology. It is described as “epidermolytic hyperkeratosisâ€. The purpose of this report is to highlight the features of epidermolytic hyperkeratosis and discuss the differential diagnosis of this histological entity.ÂReferences
Shwayder T. All about ichthyosis. Pediatr Clin North 1991; 38: 835-57.
Frost P, Weinstein GD, Van Scott EJ. The ichthyosiform dermatoses II. Autoradiographic studies of epidermal proliferation. J Invest Dermatol 1996; 47: 561-7.
Fuchs E. Genetic Skin disorders of keratin. J Invest Dermatol 1992; 99: 671-4.
Comton JG, Digiovanna JJ, Santucci SK. Linkage of epidermolytic hyperkeratosis to the type II keratin gene cluster on chromosome 12q. Nat Genet 1992; 1: 301-5.
Rothnagel JA, Dominey AM, Dempsey MD. Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science 1992; 257: 1128-30.
DiCiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994; 130: 1026-35.
Holbrook KA, Dale BA, Sybert VP. Epidermolytic hyperkeratosis: ultra structure and biochemistry of skin and amniotic fluid cells from two affected fetus and new born infants. J Invest Dermatol 1983; 80; 222-7.
Ackerman AB. Histopathological concepts of epidermolytic hyperkeratosis. Arch Dermatol 1970; 102: 253-59.
Blanchet-Bardon C, Nazarro V, Rognin C et al. Acitretin in the treatment of severe disorders of keratinization. J Am Acad Dermatol 1991; 24: 982-6.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
